Dr. Josh Rising is Pew’s director of health care programs, overseeing the medical device initiative and the improving end-of-life care project.
Before joining Pew, Rising helped establish the Office of Policy in the Food and Drug Administration’s Center for Tobacco Products. He also served as health policy analyst for the Connecticut Legislature, focusing on issues of health care access, Medicaid policy, health information technology, and health care quality. He also was legislative affairs director for the American Medical Student Association.
Rising received his medical degree and his master’s degree in public health from Boston University, completed his pediatric residency at the University of California, San Francisco, and trained for a year as a Robert Wood Johnson clinical scholar at Yale University.
Recent WorkView All
Experts from hospitals, health plans, health technology developers, medical device manufacturers, and other health care stakeholders convened December 9, 2014 to discuss the importance of medical device identification. The result: a clear message that a new tool to track medical devices can improve patient safety and the quality of care, but changes in health data systems must occur for this to... Read More
The U.S. Food and Drug Administration’s new unique device identifier (UDI) system has the potential to improve patient safety and enhance the efficiency of care at hospitals across the country. Read More
On June 10, the U.S. Department of Health and Human Services’ National Committee on Vital and Health Statistics, Subcommittee on Standards, held a hearing that discussed the incorporation and use of unique device identifiers (UDI) in administrative transactions. Josh Rising, director of drugs and medical devices, submitted testimony on the importance of including UDIs in health insurance... Read More